Jason Douglas Wilson, Chief Financial Officer at REATA PHARMACEUTICALS INC (RETA), sold 4,000 shares at $85.64 ($339K) on 2019-07-15, disclosed to the SEC on 2019-07-17.
Open-market sale of $339k RETA by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $83.93 | 1,811 | $152K | 44.9% |
| 2 | $84.73 | 989 | $84K | 24.8% |
| 3 | $85.64 | 1,200 | $103K | 30.4% |
| Total | $84.64 avg | 4,000 | $339K | 100% |
| Filing → |
| RETA | SELL | 2019-10-21 | $1.7M | — | Filing → |
| RETA | SELL | 2019-10-15 | $5.5M | — | Filing → |
| RETA | SELL | 2019-10-15 | $2.1M | — | Filing → |